Revert L
University of Barcelona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Revert L.
Digestive Diseases and Sciences | 1976
Vicente Arroyo; Juan Rodés; Miguel A. Gutiérrez-Lizárraga; Revert L
AbstractSpontaneous hyponatremia in cirrhosis with ascites is generally considered to be due to an impaired renal ability to excrete free water, to be a contraindication of diuretics, and to be a bad prognostic sign. These concepts are reviewed in this paper. 55 cirrhotics with ascites were divided into three groups. Group I consisted of 13 patients with hyponatremia and very low free-water clearance (
British Journal of Haematology | 1995
R. Torra; Joan Bladé; Aleix Cases; J. López-Pedret; Emilio Montserrat; C. Rozman; Revert L
American Journal of Nephrology | 1990
Josep M. Campistol; Manel Solé; J. Muñoz-Gómez; José López-Pedret; Revert L
C_{H_2 O}
American Journal of Nephrology | 1990
Alberto Martinez-Vea; Carmen García; Montse Carreras; Revert L; Jesés Angel Oliver
American Journal of Nephrology | 1987
Josep M. Campistol; Aleix Cases; Albert Torras; Manuel Soler; Josep Muñoz-Gómez; Jesús Montoliu; Josep López-Pedret; Revert L
, 0.07±0.26 ml/min). These patients also had poor renal function: low inulin clearance (CINU, 40.6±25.9 ml/min) and paraamino-hippurate clearance (CPAH, 383±275 ml/min). Group II consisted of 8 patients who also had hyponatremia.
American Journal of Kidney Diseases | 1985
Jesús Montoliu; Revert L
Journal of Bone and Joint Surgery, American Volume | 1990
Josep M. Campistol; Manel Solé; J. Muñoz-Gómez; Josep Riba; R Ramón; Revert L
C_{H_2 O}
Journal of Internal Medicine | 1990
J. Montoliu; J. Almirall; E. Ponz; J. M. Campistol; Revert L
Nephron | 1990
Aleix Cases; Kelly J; Sabater F; Albert Torras; Griño Mc; Lopez-Pedret J; Revert L
, CINU, and CPAH in these patients were fairly high: 5.85±1.53 ml/min, 85.7±26.2 ml/min, and 651±294 ml/min. These values are similar to those of the 34 patients without hyponatremia who make up Group III: (6.37±4.27 ml/min, 94.7±33.1 ml/min, and 598±199 ml/min). Hyponatremia in Group I could be related to the impaired free-water clearance. The mechanism of hyponatremia in Group II patients is not clear. Patients with hyponatremia and low CINU and CPAH had a negative response to diuretics and a poor prognosis. Patients with hyponatremia but with relatively good renal function had a good prognosis, similar to Group III patients. They responded to diuretics with no worsening of their hyponatremia.
American Journal of Hypertension | 1998
Patricia Fernández-Llama; Esteban Poch; Josep Oriola; Albert Botey; Francisca Rivera; Revert L
Summary. From January 1982 to December 1993, 30 patients with multiple myeloma (MM) required haemodialysis (HD) at our institution. The subgroup of 20 patients who survived more than 2 months on HD is the subject of this study. Four patients were already on HD, due to previous nephropathy, when MM was diagnosed. 13 patients presented with acute renal failure and were on dialysis from the time of diagnosis. The remaining three cases developed renal failure later in the course of the disease. The objective response rate was 40% (8/20). Only two patients could discontinue HD (one had a late partial recovery and one received a kidney graft). Mean hospitalization per year was 19.3 d. The subgroup of patients who survived < 1 year spent a mean of 38.3 d in hospital. Whereas in the subgroup with a survival > 1 year mean hospitalization days was 9.6 (P < 0.001). The median survival was 20 months and six patients survived for > 3 years. In summary, patients with MM and severe renal failure who survive the first 2 months on dialysis have an objective response rate to chemotherapy of 40% and a median survival of almost 2 years, with 30% long‐term survivors.